- Home
- LSE vs GNTA Comparison
LSE vs GNTA Comparison
Compare LSE & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSE
- GNTA
- Stock Information
- Founded
- LSE 2007
- GNTA 2014
- Country
- LSE China
- GNTA Italy
- Employees
- LSE N/A
- GNTA N/A
- Industry
- LSE Metal Fabrications
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LSE Industrials
- GNTA Health Care
- Exchange
- LSE Nasdaq
- GNTA Nasdaq
- Market Cap
- LSE 85.6M
- GNTA 70.6M
- IPO Year
- LSE 2024
- GNTA 2021
- Fundamental
- Price
- LSE $5.56
- GNTA $3.77
- Analyst Decision
- LSE
- GNTA Strong Buy
- Analyst Count
- LSE 0
- GNTA 1
- Target Price
- LSE N/A
- GNTA $25.00
- AVG Volume (30 Days)
- LSE 29.1K
- GNTA 5.7K
- Earning Date
- LSE 01-01-0001
- GNTA 01-01-0001
- Dividend Yield
- LSE N/A
- GNTA N/A
- EPS Growth
- LSE N/A
- GNTA N/A
- EPS
- LSE 0.52
- GNTA N/A
- Revenue
- LSE $69,073,374.00
- GNTA N/A
- Revenue This Year
- LSE N/A
- GNTA N/A
- Revenue Next Year
- LSE N/A
- GNTA N/A
- P/E Ratio
- LSE $10.63
- GNTA N/A
- Revenue Growth
- LSE N/A
- GNTA N/A
- 52 Week Low
- LSE $3.76
- GNTA $2.74
- 52 Week High
- LSE $14.99
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- LSE N/A
- GNTA 49.65
- Support Level
- LSE N/A
- GNTA $3.51
- Resistance Level
- LSE N/A
- GNTA $3.96
- Average True Range (ATR)
- LSE 0.00
- GNTA 0.16
- MACD
- LSE 0.00
- GNTA 0.00
- Stochastic Oscillator
- LSE 0.00
- GNTA 57.78
About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares
Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment; oil and gas engineering technical services; new energy production and operation; and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment which supplies various equipments, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.